 HIV London virus KP-1461 AIM market CEO Seattle HIV/AIDS Nasdaq IPO company Reuters Koronis Pharmaceuticals biotech mutation $15 experimental market United States viral decay acceleration Phase II clinical trials ill blood change Wedbush Securities market uncertain Gilead ViiV Healthcare joint venture GlaxoSmithKline Pfizer venture capital